Zoetis Inc (ZTS)
167.07
-0.16
(-0.10%)
USD |
NYSE |
May 03, 16:00
167.02
-0.06
(-0.03%)
After-Hours: 20:00
Zoetis Cash from Financing (Quarterly): -524.00M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -524.00M |
| December 31, 2023 | -397.00M |
| September 30, 2023 | -416.00M |
| June 30, 2023 | -494.00M |
| March 31, 2023 | -1.802B |
| December 31, 2022 | 780.00M |
| September 30, 2022 | -529.00M |
| June 30, 2022 | -610.00M |
| March 31, 2022 | -545.00M |
| December 31, 2021 | -314.00M |
| September 30, 2021 | -919.00M |
| June 30, 2021 | -290.00M |
| March 31, 2021 | -339.00M |
| December 31, 2020 | -597.00M |
| September 30, 2020 | -93.00M |
| June 30, 2020 | 1.141B |
| March 31, 2020 | -328.00M |
| December 31, 2019 | -250.00M |
| September 30, 2019 | -232.00M |
| June 30, 2019 | -226.00M |
| March 31, 2019 | -243.00M |
| December 31, 2018 | -197.00M |
| September 30, 2018 | 1.263B |
| June 30, 2018 | -271.00M |
| March 31, 2018 | -262.00M |
| Date | Value |
|---|---|
| December 31, 2017 | -967.00M |
| September 30, 2017 | 956.00M |
| June 30, 2017 | -64.00M |
| March 31, 2017 | -176.00M |
| December 31, 2016 | -128.00M |
| September 30, 2016 | -124.00M |
| June 30, 2016 | -108.00M |
| March 31, 2016 | -543.00M |
| December 31, 2015 | 1.026B |
| September 30, 2015 | -86.00M |
| June 30, 2015 | -91.00M |
| March 31, 2015 | -94.00M |
| December 31, 2014 | -42.00M |
| September 30, 2014 | -38.00M |
| June 30, 2014 | -39.00M |
| March 31, 2014 | -35.00M |
| December 31, 2013 | -28.00M |
| September 30, 2013 | -32.00M |
| June 30, 2013 | -32.00M |
| March 31, 2013 | -108.00M |
| December 31, 2012 | -78.00M |
| September 30, 2012 | -18.00M |
| June 30, 2012 | -53.00M |
| March 31, 2012 | 71.00M |
| December 31, 2011 | -152.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.802B
Minimum
Mar 2023
1.141B
Maximum
Jun 2020
-349.20M
Average
-368.00M
Median
Cash from Financing (Quarterly) Benchmarks
| Biogen Inc | -439.60M |
| Pfizer Inc | 5.442B |
| Eli Lilly and Co | -311.30M |
| Bristol-Myers Squibb Co | 14.64B |
| Amgen Inc | -1.708B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 595.00M |
| Cash from Investing (Quarterly) | -131.00M |
| Free Cash Flow | 1.75B |
| Free Cash Flow Per Share (Quarterly) | 0.9917 |
| Free Cash Flow to Equity (Quarterly) | 436.00M |
| Free Cash Flow to Firm (Quarterly) | 475.85M |
| Free Cash Flow Yield | 2.27% |